Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synergistic microstructural optimization of nickel-iron dual sites in NiFealloy/NiFe2O4 by La doping and V vacancies for boosting the oxygen evolution reaction.

Created on 16 Nov 2026

Authors

Issa Salim, Gouda Helal, Wei Zuo, Abdelrazek M Askar, Zhi Li, Xinyi Chen, Shiqi Mei, Gongzhen Cheng, Pingping Zhao

Published in

Nanoscale. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

The electrochemical surface reconstruction of transition-metal pre-catalysts offers a promising route to form metal oxyhydroxide active layers during the oxygen evolution reaction (OER), but the role of dual cationic dopants in this process remains poorly understood. Here, we report an electrochemically synthesized amorphous NiFeOOH layer on a VLa-NiFealloy/NiFe2O4 heterostructure pre-catalyst for the OER. The pre-catalyst was prepared via atmospheric reduction with sodium formate under nitrogen, followed by annealing, enabling controlled incorporation of V and La. During phase-selective doping, La preferentially saturated the oxide lattice and V selectively contracted the alloy phase, creating a maximally strained heterointerface with abundant defects. The optimized VLa-NiFealloy/NiFe2O4 catalyst achieved an exceptionally low overpotential of 265 mV at 10 mA cm-2 and sustained stability for ∼100 h at 250 mA cm-2 in 1 M KOH. Comprehensive in situ Raman spectroscopy, XPS, and HRTEM analyses revealed a dramatic electrochemical surface reconstruction pathway by vanadium leaching and lattice oxygen activation to create FeNiOOH active sites. DFT calculations confirmed that co-doping lowered the OER intermediate energy barriers of the RDS from 2.15 eV to 1.60 eV by optimizing the d-band center of Ni sites. This work provides a fundamental insight into unexplored V and La dual-dopant-triggered surface reconstruction, and offers a viable strategy for designing high-performance OER catalysts.

PMID:
43037455
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement